You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunomodulatory Agents

Showing 51 - 75 of 6,024
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Myeloma Multiple, Kahler Disease Trial in United States (Selinexor, Dexamethasone Oral, Daratumumab)

Recruiting
  • Multiple Myeloma
  • +6 more
  • Tucson, Arizona
  • +9 more
Jan 5, 2022

Patient and Healthcare Provider Satisfaction of Daratumumab Use

Recruiting
  • Multiple Myeloma
  • +5 more
  • Daratumumab
  • Frankfurt, Hessen, Germany
    Centrum für Hämatologie und Onkologie Bethanien
Aug 1, 2022

Multiple Myeloma Trial in Durham (Opaganib)

Terminated
Has Results
  • Multiple Myeloma
  • Durham, North Carolina
    Duke University Medical Center
May 24, 2021

Systemic Lupus Erythematosus Trial in China (Telitacicept, standard therapy)

Recruiting
  • Systemic Lupus Erythematosus
  • Telitacicept
  • standard therapy
  • Bengbu, Anhui, China
  • +18 more
May 22, 2022

Relapsed, Refractory Multiple Myeloma Trial in Milwaukee (RAPA-201 Autologous T cells)

Recruiting
  • Relapsed, Refractory Multiple Myeloma
  • RAPA-201 Autologous T cells
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Dec 28, 2021

Spine Metastases Trial in Miami (Prophylactic Radiotherapy, Standard of care systemic therapy)

Recruiting
  • Spine Metastases
  • Prophylactic Radiotherapy
  • Standard of care systemic therapy
  • Miami, Florida
    Miami Cancer Institute at Baptist Health South Florida
Sep 12, 2022

COVID-19 Trial in Budapest (Extracorporeal photopheresis)

Recruiting
  • COVID-19
  • Extracorporeal photopheresis
  • Budapest, Hungary
    South Pest Central Hospital, National Institute of Haematology a
May 28, 2023

Triple-Negative Breast Cancer Trial in Shanghai (Famitinib, Camrelizumab, nab-Palitaxel/Capecitabine/Eribulin

Not yet recruiting
  • Triple-Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Feb 27, 2023

Pancreatitis, Acute Necrotizing Trial in Nanjing (Thymosin Alpha 1, normal saline)

Completed
  • Pancreatitis, Acute Necrotizing
  • Thymosin Alpha 1
  • normal saline
  • Nanjing, Jiangsu, China
  • +1 more
Apr 1, 2021

Systemic Inflammatory Response, Aortic Valve Stenosis Trial in Zagreb (Placebo, Dexmedetomidine 0.5mcg/kg/h, Dexmedetomidine 1

Recruiting
  • Systemic Inflammatory Response
  • Aortic Valve Stenosis
  • Placebo
  • +2 more
  • Zagreb, Croatia
    University hospital Dubrava
Dec 4, 2022

Sarcoidosis, SARS-CoV2 Infection, Vaccine Response Impaired Trial in Chicago (Assay of (1) the level of anti-spike IgG antibody,

Recruiting
  • Sarcoidosis
  • +2 more
  • Assay of (1) the level of anti-spike IgG antibody, and (2) interferon-gamma release in response to SARS-CoV-2 antigen stimulation
  • Chicago, Illinois
    Northwestern Medicine
Dec 6, 2021

Non-alcoholic Fatty Liver Disease Trial in Taipei (275mg Oligo Fucoidan + 275mg HS Fucoxanthin, pills)

Completed
Has Results
  • Non-alcoholic Fatty Liver Disease
  • 275mg Oligo Fucoidan + 275mg HS Fucoxanthin
  • placebo pills
  • Taipei, Taiwan
    WanFangH
Mar 18, 2021

Colitis, Ulcerative Trial in Worldwide (Cobitolimod, Placebo)

Completed
Has Results
  • Colitis, Ulcerative
  • Hradec Kralove, Czechia
  • +36 more
Dec 14, 2022

Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6

Not yet recruiting
  • Grade 3b Follicular Lymphoma
  • +5 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Jun 6, 2023

Methylmalonic Acidemia (MMA) Trial run by the Selecta Biosciences, Inc. (SEL-302)

Recruiting
  • Methylmalonic Acidemia (MMA)
  • Bethesda, Maryland
    National Human Genome Research Institute, National Institutes of
Mar 9, 2023

S100A8/A9 and Innate Immunity in Liver Disease

Recruiting
  • Cirrhosis, Liver
  • +4 more
    • London Borough Of Wandsworth, London, United Kingdom
      Arjuna Singanayagam
    Mar 30, 2023

    Ventriculitis, Infectious Trial in Cairo (Probiotic Formula, Zinc)

    Recruiting
    • Ventriculitis, Infectious
    • Cairo, Egypt
      Ain shams university
    Nov 21, 2023

    Radiation Dermatitis Trial in Cairo (Imtenan Oil, Baraka Capsules)

    Recruiting
    • Radiation Dermatitis
    • Imtenan Oil
    • Baraka Capsules
    • Cairo, Egypt
      Ain Shams University Hospital
    Jan 30, 2023

    MDS Trial in Beijing (Lenalidomide, Azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Beijing, China
      Peking union medical college hospital
    Aug 16, 2023

    Immunomodulatory Effects of PCSK9 Inhibition

    Not yet recruiting
    • Atherosclerotic Cardiovascular Disease
    • +3 more
    • Contrast-enhanced CCTA
    • 99mTc-tilmanocept SPECT/CT scanning
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jan 30, 2023

    Primary Immune Thrombocytopenia (ITP) Trial in Switzerland (Eltrombopag (Revolade®), standard therapy (without eltrombopag):

    Recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • Eltrombopag (Revolade®)
    • standard therapy (without eltrombopag): HD-DXM
    • Aarau, Switzerland
    • +5 more
    Sep 5, 2022

    Triple-Negative Breast Cancer Trial in Shanghai (Camrelizumab plus Famitinib with/without nab-Palitaxel)

    Not yet recruiting
    • Triple-Negative Breast Cancer
    • Camrelizumab plus Famitinib with/without nab-Palitaxel
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center Shanghai, China, 200032
    Jan 2, 2023

    Covid19 Trial in Providence (Thymalfasin)

    Recruiting
    • Covid19
    • Providence, Rhode Island
      The Miriam Hospital
    Sep 14, 2021

    Suicidal Behavior in Adolescents

    Recruiting
    • Suicide and Depression
    • Observational Study
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Aug 27, 2021

    Pericarditis Idiopathic Recurrent Trial in Athens (Hydroxychloroquine, Colchicine)

    Not yet recruiting
    • Pericarditis Idiopathic Recurrent
    • Athens, Attiki, Greece
      "Hippokration" General Hospital of Athens
    Feb 20, 2023